Taking on board higher near-term expenses
22/06/22 -"However, these expenses are investment into growth and should continue to support Astra’s sector-leading top-line growth in the coming years. Overall, our positive stock recommendation on the pharma ..."
Pages
62
Language
English
Published on
22/06/22
You may also be interested by these reports :
22/06/22
However, these expenses are investment into growth and should continue to support Astra’s sector-leading top-line growth in the coming years. ...
15/06/22
Roadshow highlights: CFO Suter shows himself very confident to reach Siegfried’s 2022E guidance and mid-term targets
03/06/22
Sentiment for the current business environment might be far better than expected by many market participants, but question mark on the development ...
02/06/22
We have revised downwards our profitability expectations due to the significant price increases for consumables and single-use products. Compounded ...